Alphatec Holdings, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Alphatec Holdings, Inc. (ATEC) filed its Q1 2024 10-Q, detailing financial performance and operational data.</b>

AI Summary

Alphatec Holdings, Inc. (ATEC) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Alphatec Holdings, Inc. filed a 10-Q report for the period ending March 31, 2024. The filing includes data related to various financial statement items and disclosures. Key dates mentioned include March 31, 2024, and December 31, 2023, for financial reporting. The company is incorporated in Delaware and operates in the Surgical & Medical Instruments & Apparatus industry. Specific financial instruments and agreements like the Braidwell Term Loan and Senior Convertible Notes are referenced.

Why It Matters

For investors and stakeholders tracking Alphatec Holdings, Inc., this filing contains several important signals. This 10-Q filing provides a quarterly update on Alphatec's financial health and operational status, crucial for investors to assess recent performance. The detailed disclosures within the report offer insights into the company's assets, liabilities, equity, and specific financial instruments, aiding in valuation and risk assessment.

Risk Assessment

Risk Level: medium — Alphatec Holdings, Inc. shows moderate risk based on this filing. The filing is a standard 10-Q, which typically contains a mix of positive and negative information, making the overall sentiment neutral. Specific financial details and risk factors will determine the precise risk level.

Analyst Insight

Review the detailed financial statements and risk factors in the 10-Q to understand Alphatec's current financial position and future outlook.

Key Numbers

• 2024-03-31 — Reporting Period End Date (Conformed period of report)
• 2024-05-07 — Filing Date (Filed as of date)
• 0001350653 — Central Index Key (Company identifier)
• 3841 — SIC Code (Standard Industrial Classification for Surgical & Medical Instruments & Apparatus)

Key Players & Entities

• Alphatec Holdings, Inc. (company) — Filer name
• 2024-03-31 (date) — Conformed period of report
• 2024-05-07 (date) — Filed as of date
• 0001350653 (company) — Central Index Key
• 3841 (industry) — Standard Industrial Classification
• DE (jurisdiction) — State of incorporation
• 760-431-9286 (phone) — Business phone
• Braidwell Term Loan (financial_instrument) — Referenced financial agreement

FAQ

Key Dates

• 2024-03-31: Quarterly Period End — End of the reporting period for the 10-Q filing.
• 2024-05-07: Filing Date — Date the 10-Q was officially filed with the SEC.

Glossary

10-Q

A quarterly report required by the U.S. Securities and Exchange Commission (SEC). (Provides an update on the company's financial performance and condition between annual reports.)

Central Index Key (CIK)

A unique identifier assigned to each person or entity that files with the SEC. (Helps in tracking filings and identifying specific companies within SEC databases.)

Filing Documents

• atec-20240331.htm (10-Q) — 1428KB
• atec-ex31_1.htm (EX-31.1) — 13KB
• atec-ex31_2.htm (EX-31.2) — 13KB
• atec-ex32.htm (EX-32) — 17KB
• 0000950170-24-054691.txt (&nbsp;) — 7335KB
• atec-20240331.xsd (EX-101.SCH) — 1204KB
• atec-20240331_htm.xml (XML) — 1208KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Operations (unaudited) 4 Condensed Consolidated Statements of Comprehensive Loss (unaudited) 5 Condensed Consolidated Statements of Stockholders' Equity (Deficit) (unaudited) 6 Condensed Consolidated Statements of Cash Flows (unaudited) 7 Notes to Condensed Consolidated Financial Statements (unaudited) 8 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 21 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 27 Item 4.

Controls and Procedures

Controls and Procedures 27

– OTHER INFORMATION

PART II – OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 28 Item 1A.

Risk Factors

Risk Factors 28 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 28 Item 5. Other Information 28 Item 6. Exhibits 29

SIGNATURES

SIGNATURES 30 2 Table of Contents

FINANCI AL INFORMATION

PART I. FINANCI AL INFORMATION

Financ ial Statements

Item 1. Financ ial Statements ALPHATEC HOLDINGS, INC. CONDENSED CONSOLIDA TED BALANCE SHEETS (In thousands, except for par value data) March 31, 2024 December 31, 2023 Assets (Unaudited) Current assets: Cash and cash equivalents $ 144,085 $ 220,970 Accounts receivable, net of allowances of $ 1,831 and $ 910 , respectively 88,648 72,613 Inventories 152,981 136,842 Prepaid expenses and other current assets 19,578 20,666 Total current assets 405,292 451,091 Property and equipment, net 171,128 149,835 Right-of-use assets 23,631 26,410 Goodwill 72,249 73,003 Intangible assets, net 99,814 102,451 Other assets 2,467 2,418 Total assets $ 774,581 $ 805,208 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 60,358 $ 48,985 Accrued expenses and other current liabilities 87,509 87,712 Contract liabilities 13,632 13,910 Short-term debt 2,548 1,808 Current portion of operating lease liabilities 5,239 5,159 Total current liabilities 169,286 157,574 Long-term debt 511,889 511,035 Operating lease liabilities, less current portion 21,069 23,677 Other long-term liabilities 11,182 11,203 Commitments and contingencies (Note 9) Redeemable preferred stock, $ 0.0001 par value; 20,000 shares authorized at March 31, 2024 and December 31, 2023; 3,319 shares issued and outstanding at March 31, 2024 and December 31, 2023 23,603 23,603 Stockholders' equity: Common stock, $ 0.0001 par value; 200,000 authorized; 142,422 shares issued and 142,410 shares outstanding at March 31, 2024; and 139,257 shares issued and 139,245 shares outstanding at December 31, 2023 14 14 Treasury stock, 1,808 shares, at cost ( 25,097 ) ( 25,097 ) Additional paid-in capital 1,240,879 1,230,484 Accumulated other comprehensive loss ( 10,787 ) ( 8,323 ) Accumulated deficit ( 1,167,457 ) ( 1,118,962

View Full Filing

View this 10-Q filing on SEC EDGAR